Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program
作者： Graham Dark , Maurizio Marangolo , Giorgio V. Scagliotti , Rob J. van Klaveren , Roberto Labianca
DOI: 10.1097/JTO.0B013E31817C73EC
关键词:
摘要: … patients (both chemonaïve and pretreated) who received treatment with single-agent pemetrexed in the EAP. The subset of patients who received pemetrexed in combination with either …
jto.org
elsevier.com
sci-hub.se 参考文章(29)
Jens Benn Sørensen, Stein Sundstrøm, Katharina Perell, Anne-Kathrine Thielsen, Pemetrexed as Second-Line Treatment in Malignant Pleural Mesothelioma after Platinum-Based First-Line Treatment Journal of Thoracic Oncology. ,vol. 2, pp. 147- 152 ,(2007) , 10.1097/JTO.0B013E31802F3813
C Zuch, L Ramani, G Grandi, C Bianchi, A Brollo, L Giarelli, Latency periods in asbestos-related mesothelioma of the pleura. European Journal of Cancer Prevention. ,vol. 6, pp. 162- 166 ,(1997)
Donald W. Cockcroft, Henry Gault, Prediction of Creatinine Clearance from Serum Creatinine Nephron. ,vol. 16, pp. 31- 41 ,(1976) , 10.1159/000180580
P Baas, A Ardizzoni, F Grossi, Kristiaan Nackaerts, G Numico, E Van Marck, M van de Vijver, F Monetti, MJA Smid-Geirnaerdt, N van Zandwijk, C Debruyne, Catherine Legrand, Giuseppe Giaccone, EORTC Lung Cancer Group, The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992). European Journal of Cancer. ,vol. 39, pp. 353- 357 ,(2003) , 10.1016/S0959-8049(02)00668-8
R. Thödtmann, H. Depenbrock, H. Dumez, J. Blatter, R. D. Johnson, A. van Oosterom, A.-R. Hanauske, Clinical and Pharmacokinetic Phase I Study of Multitargeted Antifolate (LY231514) in Combination With Cisplatin Journal of Clinical Oncology. ,vol. 17, pp. 3009- 3016 ,(1999) , 10.1200/JCO.1999.17.10.3009
Ulrich Gatzemeier, Paul Taylor, Joachim von Pawel, Bruno Castagneto, Graham Dark, Maurizio Marangolo, Rob J. Van Klaveren, Jan Van Meerbeeck, Susumu Adachi, Johannes Blatter, C5-03: Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP) Journal of Thoracic Oncology. ,vol. 2, pp. S372- S373 ,(2007) , 10.1097/01.JTO.0000283218.40896.16
Hedy L. Kindler, Chandra P. Belani, James E. Herndon, Nicholas J. Vogelzang, Yasunosuke Suzuki, Mark R. Green, Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B. Cancer. ,vol. 86, pp. 1985- 1991 ,(1999) , 10.1002/(SICI)1097-0142(19991115)86:10<1985::AID-CNCR15>3.0.CO;2-H
Pasi A. Jänne, Antoinette J. Wozniak, Chandra P. Belani, Mary-Louise Keohan, Helen J. Ross, Jonathan A. Polikoff, David M. Mintzer, Zhishen Ye, Matthew J. Monberg, Coleman K. Obasaju, Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program Journal of Thoracic Oncology. ,vol. 1, pp. 506- 512 ,(2006) , 10.1016/S1556-0864(15)30351-8
ØP Solheim, G Sæter, AM Finnanger, AE Stenwig, High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study. British Journal of Cancer. ,vol. 65, pp. 956- 960 ,(1992) , 10.1038/BJC.1992.200
Debby P.M. van den Bogaert, Ellen M. Pouw, Gerda van Wijhe, René M. Vernhout, Veerle F.M. Surmont, Henk C. Hoogsteden, Rob J. van Klaveren, Pemetrexed Maintenance Therapy in Patients with Malignant Pleural Mesothelioma Journal of Thoracic Oncology. ,vol. 1, pp. 25- 30 ,(2006) , 10.1016/S1556-0864(15)31509-4